Publications by authors named "Sandrine Caron"

35Publications

Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects.

J Clin Endocrinol Metab 2017 10;102(10):3783-3794

Université Lille, INSERM, Centre Hospitalier Universitaire de Lille, Institut Pasteur de Lille, U1011-European Genomic Institute for Diabetes, F-59000 Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2017-01397DOI Listing
October 2017

Screening strategy to generate cell specific recombination: a case report with the RIP-Cre mice.

Transgenic Res 2015 Oct 20;24(5):803-12. Epub 2015 Jun 20.

European Genomic Institute for Diabetes (EGID), FR 3508, 59000, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11248-015-9889-1DOI Listing
October 2015

O-GlcNAcylation Links ChREBP and FXR to Glucose-Sensing.

Front Endocrinol (Lausanne) 2014 13;5:230. Epub 2015 Jan 13.

U1016, Institut Cochin, INSERM , Paris , France ; UMR 8104, CNRS , Paris , France ; Sorbonne Paris Cité, Université Paris Descartes , Paris , France.

View Article

Download full-text PDF

Source
http://journal.frontiersin.org/article/10.3389/fendo.2014.00
Publisher Site
http://dx.doi.org/10.3389/fendo.2014.00230DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292737PMC
January 2015

Cell-specific dysregulation of microRNA expression in obese white adipose tissue.

J Clin Endocrinol Metab 2014 Aug 23;99(8):2821-33. Epub 2014 Apr 23.

European Genomic Institute for Diabetes (F.O., C.G., D.M., Y.B., O.M.-C., E.B., S.C., D.D., F.P., H.D., J.E., B.S., P.L.), Inserm Unité Mixte de Recherche Unité 1011 (F.O., C.G., D.M., Y.B., O.M.-C., E.B., S.C., D.D., H.D., J.E., B.S., P.L.), Université Lille 2 (F.O., C.G., D.M., Y.B., O.M.-C., E.B., S.C., D.D., F.P., H.D., J.E., B.S., P.L.), and Inserm Unité Mixte de Recherche Unité 859 (F.P.), F-59000 Lille, France; Institut Pasteur de Lille (F.O., C.G., D.M., Y.B., O.M.-C., E.B., S.C., D.D., H.D., J.E., B.S., P.L.), F-59019 Lille, France; and Centre Hospitalier Régional Universitaire de Lille (F.P.), F-59045, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2013-4259DOI Listing
August 2014

Glucose-lowering effects of intestinal bile acid sequestration through enhancement of splanchnic glucose utilization.

Trends Endocrinol Metab 2014 May 11;25(5):235-44. Epub 2014 Apr 11.

European Genomic Institute for Diabetes (EGID), FR 3508, 59000 Lille, France; Université Lille 2, 59000 Lille, France; Institut National de la Santé et de la Recherche Médicale (INSERM) Unité Mixte de Recherche (UMR) 1011, 59000 Lille, France; Institut Pasteur de Lille, 59000 Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tem.2014.03.007DOI Listing
May 2014

Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Hepatology 2014 Jan 8;59(1):121-9. Epub 2013 Nov 8.

Department of Endocrinology, Diabetology and Metabolism, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.26510DOI Listing
January 2014

Glucose sensing O-GlcNAcylation pathway regulates the nuclear bile acid receptor farnesoid X receptor (FXR).

Hepatology 2014 May 24;59(5):2022-33. Epub 2014 Mar 24.

European Genomic Institute for Diabetes (EGID), Lille, France; INSERM UMR1011, Lille, France; Univ Lille 2, Lille, France; Institut Pasteur de Lille, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.26710DOI Listing
May 2014

PNPLA3 is regulated by glucose in human hepatocytes, and its I148M mutant slows down triglyceride hydrolysis.

Am J Physiol Endocrinol Metab 2012 May 14;302(9):E1063-9. Epub 2012 Feb 14.

Minerva Foundation Institute for Medical Research, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://www.physiology.org/doi/10.1152/ajpendo.00125.2011
Publisher Site
http://dx.doi.org/10.1152/ajpendo.00125.2011DOI Listing
May 2012

Bile acid metabolism and the pathogenesis of type 2 diabetes.

Curr Diab Rep 2011 Jun;11(3):160-6

University Lille Nord de France; INSERM, U1011; UDSL; Institut Pasteur de Lille, 1 rue du Professeur Calmette, BP245, 59019 Lille, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11892-011-0187-x
Publisher Site
http://dx.doi.org/10.1007/s11892-011-0187-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338411PMC
June 2011

Activation of the farnesoid X receptor represses PCSK9 expression in human hepatocytes.

FEBS Lett 2008 Mar 25;582(6):949-55. Epub 2008 Feb 25.

INSERM, U915, CHU Hôtel Dieu, NORD, Nantes F-44000, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.febslet.2008.02.038DOI Listing
March 2008

Liver-specific peroxisome proliferator-activated receptor alpha target gene regulation by the angiotensin type 1 receptor blocker telmisartan.

Diabetes 2008 May 9;57(5):1405-13. Epub 2008 Jan 9.

Center for Cardiovascular Research, Institute of Pharmacology, Charité-Universitätsmedizin Berlin, Hessische Str. 3-4, 10115 Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/db07-0839DOI Listing
May 2008

FXR-deficiency confers increased susceptibility to torpor.

FEBS Lett 2007 Nov 12;581(27):5191-8. Epub 2007 Oct 12.

Institut Pasteur de Lille, Département d'Athérosclérose, Lille F-59019, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.febslet.2007.09.064DOI Listing
November 2007

The farnesoid X receptor induces fetuin-B gene expression in human hepatocytes.

Biochem J 2007 Nov;407(3):461-9

Tokyo New Research Laboratories I, Pharmaceutical Division, Kowa Company Ltd, 2-17-43 Noguchicho, Higashimurayama, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1042/BJ20070658DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275064PMC
November 2007

Bile acids, farnesoid X receptor, atherosclerosis and metabolic control.

Curr Opin Lipidol 2007 Jun;18(3):289-97

Center for Liver, Digestive and Metabolic Diseases, University Medical Center Groningen, The Netherlands.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00041433-200706000-000
Publisher Site
http://dx.doi.org/10.1097/MOL.0b013e3281338d08DOI Listing
June 2007

FXR: More than a bile acid receptor?

Endocrinology 2006 Sep;147(9):4022-4

Département d'Athérosclérose, Institut Pasteur de Lille, Lille F-59019, France.

View Article

Download full-text PDF

Source
https://academic.oup.com/endo/article-lookup/doi/10.1210/en.
Publisher Site
http://dx.doi.org/10.1210/en.2006-0701DOI Listing
September 2006

STAT5 and Oct-1 form a stable complex that modulates cyclin D1 expression.

Mol Cell Biol 2003 Dec;23(24):8934-45

Department of Hematology, Institut Cochin, INSERM U567, CNRS UMR 8104, Université René Descartes, 123 Boulevard Port-Royal, 75014 Paris, France.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC309603PMC
http://dx.doi.org/10.1128/mcb.23.24.8934-8945.2003DOI Listing
December 2003